Molecular Epidemiology and Antimicrobial Resistance of Clostridioides difficile in Hospitalized Patients From Mexico

被引:13
作者
Aguilar-Zamora, Emmanuel [1 ,2 ]
Weimer, Bart C. [3 ]
Torres, Roberto C. [1 ]
Gomez-Delgado, Alejandro [1 ]
Ortiz-Olvera, Nayeli [4 ]
Aparicio-Ozores, Gerardo [5 ]
Barbero-Becerra, Varenka J. [6 ]
Torres, Javier [1 ]
Camorlinga-Ponce, Margarita [1 ]
机构
[1] CMN Siglo21, UMAE Pediat, Unidad Invest Med Enfermedades Infecciosas & Paras, IMSS, Mexico City, Mexico
[2] Inst Politecn Nacl, Escuela Nacl Ciencias Biol, Mexico City, Mexico
[3] Univ Calif, Sch Vet Med, Dept Populat Hlth & Reprod, Pathogen Genome Project 100K, Davis, CA USA
[4] Inst Mexicano Seguro Social, Dept Gastroenterol, UMAE Hosp Especial, Mexico City, Mexico
[5] Inst Politecn Nacl, Dept Microbiol, Escuela Nac Ciencias Biol, Mexico City, Mexico
[6] MedicaSur Clin Fdn, Translat Res Unit, Mexico City, Mexico
关键词
Clostridioides difficile; antibiotic resistance; whole-genome sequencing; mutation; multilocus sequence typing; adults and children; FLUOROQUINOLONE RESISTANCE; VIRULENCE FACTORS; SUSCEPTIBILITY; EVOLUTION; STRAINS; GENOME; INFECTION; INSIGHTS; TOXIN; SURVEILLANCE;
D O I
10.3389/fmicb.2021.787451
中图分类号
Q93 [微生物学];
学科分类号
071005 ; 100705 ;
摘要
Clostridioides difficile is a global public health problem, which is a primary cause of antibiotic-associated diarrhea in humans. The emergence of hypervirulent and antibiotic-resistant strains is associated with the increased incidence and severity of the disease. There are limited studies on genomic characterization of C. difficile in Latin America. We aimed to learn about the molecular epidemiology and antimicrobial resistance in C. difficile strains from adults and children in hospitals of Mexico. We studied 94 C. difficile isolates from seven hospitals in Mexico City from 2014 to 2018. Whole-genome sequencing (WGS) was used to determine the genotype and examine the toxigenic profiles. Susceptibility to antibiotics was determined by E-test. Multilocus sequence typing (MLST) was used to determine allelic profiles. Results identified 20 different sequence types (ST) in the 94 isolates, mostly clade 2 and clade 1. ST1 was predominant in isolates from adult and children. Toxigenic strains comprised 87.2% of the isolates that were combinations of tcdAB and cdtAB (tcdA+/tcdB+/cdtA+/cdtB+, followed by tcdA+/tcdB+/cdtA-/cdtB-, tcdA-/tcdB+/cdtA-/ cdtB-, and tcdA-/tcdB-/cdtA+/cdtB+). Toxin profiles were more diverse in isolates from children. All 94 isolates were susceptible to metronidazole and vancomycin, whereas a considerable number of isolates were resistant to clindamycin, fluroquinolones, rifampicin, meropenem, and linezolid. Multidrug-resistant isolates (>= 3 antibiotics) comprised 65% of the isolates. The correlation between resistant genotypes and phenotypes was evaluated by the kappa test. Mutations in rpoB and rpoC showed moderate concordance with resistance to rifampicin and mutations in fusA substantial concordance with fusidic acid resistance. cfrE, a gene recently described in one Mexican isolate, was present in 65% of strains linezolid resistant, all ST1 organisms. WGS is a powerful tool to genotype and characterize virulence and antibiotic susceptibility patterns.
引用
收藏
页数:14
相关论文
共 80 条
  • [1] Prevalence and association of macrolide-lincosamide- streptogramin B (MLSB) resistance with resistance to moxifloxacin in Clostridium difficile
    Ackermann, G
    Degner, A
    Cohen, SH
    Silva, J
    Rodloff, AC
    [J]. JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY, 2003, 51 (03) : 599 - 603
  • [2] Rapid spread of Clostridium difficile NAP1/027/ST1 in Chile confirms the emergence of the epidemic strain in Latin America
    Aguayo, C.
    Flores, R.
    Levesque, S.
    Araya, P.
    Ulloa, S.
    Lagos, J.
    Hormazabal, J. C.
    Tognarelli, J.
    Ibanez, D.
    Pidal, P.
    Duery, O.
    Olivares, B.
    Fernandez, J.
    [J]. EPIDEMIOLOGY AND INFECTION, 2015, 143 (14) : 3069 - 3073
  • [3] Alvarez Ana M, 2019, Adv Pediatr, V66, P263, DOI 10.1016/j.yapd.2019.03.010
  • [4] [Anonymous], 2018, CLSI Document M100-S28
  • [5] Azimirad Masoumeh, 2018, Gastroenterol Hepatol Bed Bench, V11, P59
  • [6] Microbiological features, epidemiology, and clinical presentation of Clostridioides difficile strains from MLST Clade 2: A narrative review
    Badilla-Lobo, Adriana
    Rodriguez, Cesar
    [J]. ANAEROBE, 2021, 69
  • [7] Clostridium difficile Infections: A Global Overview of Drug Sensitivity and Resistance Mechanisms
    Banawas, Saeed S.
    [J]. BIOMED RESEARCH INTERNATIONAL, 2018, 2018
  • [8] Microbiological characteristics of human and animal isolates of Clostridioides difficile in Italy: Results of the Istituto Superiore di Sanita in the years 2006-2016
    Barbanti, Fabrizio
    Spigaglia, Patrizia
    [J]. ANAEROBE, 2020, 61
  • [9] Bletz S, 2018, J CLIN MICROBIOL, V56, DOI [10.1128/jcm.01987-17, 10.1128/JCM.01987-17]
  • [10] ResFinder 4.0 for predictions of phenotypes from genotypes
    Bortolaia, Valeria
    Kaas, Rolf S.
    Ruppe, Etienne
    Roberts, Marilyn C.
    Schwarz, Stefan
    Cattoir, Vincent
    Philippon, Alain
    Allesoe, Rosa L.
    Rebelo, Ana Rita
    Florensa, Alfred Ferrer
    Fagelhauer, Linda
    Chakraborty, Trinad
    Neumann, Bernd
    Werner, Guido
    Bender, Jennifer K.
    Stingl, Kerstin
    Minh Nguyen
    Coppens, Jasmine
    Xavier, Basil Britto
    Malhotra-Kumar, Surbhi
    Westh, Henrik
    Pinholt, Mette
    Anjum, Muna F.
    Duggett, Nicholas A.
    Kempf, Isabelle
    Nykasenoja, Suvi
    Olkkola, Satu
    Wieczorek, Kinga
    Amaro, Ana
    Clemente, Lurdes
    Mossong, Joel
    Losch, Serge
    Ragimbeau, Catherine
    Lund, Ole
    Aarestrup, Frank M.
    [J]. JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY, 2020, 75 (12) : 3491 - 3500